OrbiMed’s Aurinia Pharmaceuticals AUPH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q3 | – | Sell |
-6,069,032
| Closed | -$78.7M | – | 171 |
|
|
2021
Q2 | $78.7M | Hold |
6,069,032
| – | – | 0.8% | 41 |
|
|
2021
Q1 | $78.8M | Buy |
6,069,032
+1,315,032
| +28% | +$17.1M | 0.74% | 42 |
|
|
2020
Q4 | $65.7M | Hold |
4,754,000
| – | – | 0.58% | 49 |
|
|
2020
Q3 | $70M | Buy |
4,754,000
+3,557,653
| +297% | +$52.4M | 0.88% | 34 |
|
|
2020
Q2 | $19.4M | Sell |
1,196,347
-140,200
| -10% | -$2.28M | 0.27% | 78 |
|
|
2020
Q1 | $19.4M | Sell |
1,336,547
-1,008,900
| -43% | -$14.6M | 0.33% | 67 |
|
|
2019
Q4 | $47.5M | Sell |
2,345,447
-1,185,555
| -34% | -$24M | 0.68% | 46 |
|
|
2019
Q3 | $18.9M | Hold |
3,531,002
| – | – | 0.36% | 66 |
|
|
2019
Q2 | $23.2M | Buy |
3,531,002
+381,192
| +12% | +$2.51M | 0.36% | 62 |
|
|
2019
Q1 | $20.5M | Buy |
+3,149,810
| New | +$20.5M | 0.32% | 72 |
|
|
2018
Q3 | – | Sell |
-167,419
| Closed | -$943K | – | 151 |
|
|
2018
Q2 | $943K | Sell |
167,419
-458,856
| -73% | -$2.58M | 0.01% | 133 |
|
|
2018
Q1 | $3.25M | Sell |
626,275
-1,171,125
| -65% | -$6.08M | 0.04% | 119 |
|
|
2017
Q4 | $8.14M | Hold |
1,797,400
| – | – | 0.1% | 107 |
|
|
2017
Q3 | $11.3M | Hold |
1,797,400
| – | – | 0.11% | 102 |
|
|
2017
Q2 | $11M | Hold |
1,797,400
| – | – | 0.12% | 96 |
|
|
2017
Q1 | $13.2M | Buy |
+1,797,400
| New | +$13.2M | 0.15% | 88 |
|